Mark Liu Ph.D., 劉家宏 博士

Senior Director, Big Data Division, Meridigen Biotech Co. 宣捷生技

Meridigen Biotech co. was founded in 2011, committed to mesenchymal stem cells (MSCs) research and drug development. The company has full access to the sources of stem cells. We take good care of the industrial chain all the way from R&D, manufacturing and sales. With integrity and persistence, Meridigen expects to better the quality of human life and bring visionary treatment to the World.

The company has full access to the sources of stem cells. We take good care of the industrial chain all the way from R&D, manufacturing and sales. With integrity and persistence, Meridigen expects to better the quality of human life and bring visionary treatment to the World.